SCHEMBL11293992

SCHEMBL11293992

CCCCCCCCCCCCCC(=O)OC(=O)C(F)(F)F

nearest known ligand 0.57

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
FAAH O00519 11/20 0.57
CES1 P23141 7/20 0.57
CES2 O00748 3/20 0.57
MEN1 O00255 1/20 0.57
CYP1A2 P05177 1/20 0.57
KMT2A Q03164 1/20 0.57
HSD17B10 Q99714 1/20 0.57
DGKA P23743 1/20 0.52
LMNA P02545 2/20 0.48
PAM P19021 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6624090 1.00 FAAH (0.57) FAAHCES1CES2MEN1CYP1A2
SCHEMBL6621021 1.00 FAAH (0.57) FAAHCES1CES2MEN1CYP1A2
SCHEMBL31140192 1.00 FAAH (0.57) FAAHCES1CES2MEN1CYP1A2
SCHEMBL6619179 1.00 FAAH (0.57) FAAHCES1CES2MEN1CYP1A2
SCHEMBL28577564 1.00 FAAH (0.57) FAAHCES1CES2MEN1CYP1A2
SCHEMBL28779284 1.00 FAAH (0.57) FAAHCES1CES2MEN1CYP1A2
SCHEMBL4631696 1.00 FAAH (0.57) FAAHCES1CES2MEN1CYP1A2
SCHEMBL10499113 1.00 FAAH (0.57) FAAHCES1CES2MEN1CYP1A2
SCHEMBL6566731 0.98 FAAH (0.55) FAAHCES1CES2MEN1CYP1A2
SCHEMBL6563264 0.98 FAAH (0.55) FAAHCES1CES2MEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3681497-A1 PROTEIN KINASE C INHIBITION TO EXTEND TISSUE PLASMINOGEN ACTIVATOR TREATMENT FOR ISCHEMIC DISEASE The Regents of The University of Michigan (US) 2020-07-22 EP claimed
WO-2019055589-A1 PROTEIN KINASE C INHIBITION TO EXTEND TISSUE PLASMINOGEN ACTIVATOR TREATMENT FOR ISCHEMIC DISEASE THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2019-03-21 WO claimed
US-20190076510-A1 PROTEIN KINASE C INHIBITION TO EXTEND TISSUE PLASMINOGEN ACTIVATOR TREATMENT FOR ISCHEMIC DISEASE THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2019-03-14 US claimed
EP-3681497-A1 PROTEIN KINASE C INHIBITION TO EXTEND TISSUE PLASMINOGEN ACTIVATOR TREATMENT FOR ISCHEMIC DISEASE The Regents of The University of Michigan (US) 2020-07-22 EP disclosed
WO-2019055589-A1 PROTEIN KINASE C INHIBITION TO EXTEND TISSUE PLASMINOGEN ACTIVATOR TREATMENT FOR ISCHEMIC DISEASE THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2019-03-21 WO disclosed
US-20190076510-A1 PROTEIN KINASE C INHIBITION TO EXTEND TISSUE PLASMINOGEN ACTIVATOR TREATMENT FOR ISCHEMIC DISEASE THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2019-03-14 US disclosed
EP-0024971-B1 NICKEL CARBOXYLATES, THEIR PREPARATION, THEIR USE IN A CATALYTIC COMPOSITION, THE USE OF THIS COMPOSITION IN THE OLIGOMERISATION OF MONOOLEFINES Institut Français du Pétrole (FR) 1982-12-15 EP disclosed
EP-0024971-A1 Nickel carboxylates, their preparation, their use in a catalytic composition, the use of this composition in the oligomerisation of monoolefines Institut Français du Pétrole (FR) 1981-03-11 EP disclosed